Analysis

Kailera Therapeutics, Inc. (KLRA) Stock Analysis

Kailera Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to KLRA.

websiteKLRA/analysis/KLRA

Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to KLRA.

Stock profile

Ticker

KLRA

Asset type

Stock

Market cap

$2.58B

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Kailera Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • KLRA primary listing

Latest Kailera Therapeutics, Inc. news

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

WALTHAM, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA), a clinical-stage biotechnology company focused on elevating the next era of obesity c...

Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates

Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates

Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company

Kailera Therapeutics Announces Pricing of Initial Public Offering

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the...

Research sections

Valuation

Review valuation context for Kailera Therapeutics, Inc..

Future growth

Review future growth context for Kailera Therapeutics, Inc..

Past performance

Review past performance context for Kailera Therapeutics, Inc..

Financial health

Review financial health context for Kailera Therapeutics, Inc..

Dividend

Review dividend context for Kailera Therapeutics, Inc..

Management

Review management context for Kailera Therapeutics, Inc..

Ownership

Review ownership context for Kailera Therapeutics, Inc..

Other information

Review other information context for Kailera Therapeutics, Inc..

Community

Review community context for Kailera Therapeutics, Inc..